โœจ Health and Fisheries Notices




11 MARCH NEW ZEALAND GAZETTE 765

customary food gathering purposes from within the whole or any part of the area/rohe moana. No customary food gathering of fisheries resources may take place in the area/rohe moana without authorisation from the Tangata Tiaki/Kaitiaki.

Dated at Wellington this 9th day of March 1999.

Hon. DAVID CARTER, Associate Minister for Food, Fibre, Biosecurity and Border Control.

g01907


Health

Medicines Act 1981

Consent to the Distribution of Changed Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act and are set out in the Schedule hereto:

Schedule

Name and Strength Form Name and Address of Manufacturer Proprietary Name (if any)
Norethisterone acetate 0.5 mg, oestradiol hemihydrate 1.03 mg equivalent to 1 mg oestradiol Tablets, film coated Novo Nordisk A/S., Maaloev, Denmark Kliovance
Quetiapine fumarate 28.78 mg, 115.13 mg, 230.26 mg equivalent to 25 mg, 100 mg, 200 mg quetiapine Tablets, film coated Zeneca Pharmaceuticals Group, Newark, Delaware, United States of America; and Zeneca Pharmaceuticals, Macclesfield, Cheshire, England Seroquel

Dated this 4th day of March 1999.

GILLIAN GREW, Chief Advisor, Regulation and Safety (acting), pursuant to delegation given by the Minister of Health on the 20th day of February 1997.

g01825

Consent to the Distribution of a New Medicine

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the Schedule hereto:

Schedule

Name and Strength Form Name and Address of Manufacturer Proprietary Name (if any)
Flutamide 250 mg Tablet Generics (UK) Limited, Potters Bar, Hertfordshire, United Kingdom Flutamin
Cefaclor monohydrate 405.27 mg equivalent to 375 mg cefaclor anhydrous Tablet, film coated Ranbaxy Laboratories Limited, Dewas, Madhya Pradesh, India Locef SR
Sodium hyaluronate 1% w/v Irrigation, eye Fermentech Medical Limited, Edinburgh, Scotland, United Kingdom Ophthalin

Dated this 4th day of March 1999.

GILLIAN GREW, Chief Advisor, Regulation and Safety (acting), pursuant to delegation given by the Minister of Health on the 20th day of February 1997.

g01828

Consent to the Distribution of a New Medicine

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the Schedule hereto:

Schedule

Name and Strength Form Name and Address of Manufacturer Proprietary Name (if any)
Bromhexine hydrochloride 0.8 mg/mL, pholcodine 1 mg/mL Syrup 3M Pharmaceuticals (Australia) Pty Limited, Thornleigh, New South Wales, Australia Duro-Tuss Expectorant
Succinylated gelatin 40g/L Infusion, solution B Braun Medical AG., St. Gallen, Switzerland Gelofusine
Hydrocortisone acetate 0.5% w/w Cream, topical Taro Pharmaceuticals Inc., Bramelea, Ontario, Canada Hydrocortisone Cream ยฝ%


Next Page →

PDF embedding disabled (Crown copyright)

View this page online at:


VUW Te Waharoa PDF NZ Gazette 1999, No 30


NZLII PDF NZ Gazette 1999, No 30





โœจ LLM interpretation of page content

๐Ÿชถ Fisheries (South Island Customary Fishing) Notice (No. 10) 1999 (continued from previous page)

๐Ÿชถ Mฤori Affairs
9 March 1999
Customary Fishing, Tangata Tiaki, Waihao
  • Hon. DAVID CARTER, Associate Minister for Food, Fibre, Biosecurity and Border Control

๐Ÿฅ Consent to the Distribution of Changed Medicines

๐Ÿฅ Health & Social Welfare
4 March 1999
Medicines, Distribution, Approval
  • GILLIAN GREW, Chief Advisor, Regulation and Safety (acting)

๐Ÿฅ Consent to the Distribution of a New Medicine

๐Ÿฅ Health & Social Welfare
4 March 1999
Medicines, Distribution, Approval
  • GILLIAN GREW, Chief Advisor, Regulation and Safety (acting)

๐Ÿฅ Consent to the Distribution of a New Medicine

๐Ÿฅ Health & Social Welfare
4 March 1999
Medicines, Distribution, Approval
  • GILLIAN GREW, Chief Advisor, Regulation and Safety (acting)